Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neuroectodermal Tumors × Vincristine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma 12 Lymphoma, Non-Hodgkin 10 Lymphoma, Mantle-Cell 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Follicular 6 Lymphoma, B-Cell 6 Burkitt Lymphoma 6 Immunoblastic Lymphadenopathy 5 Rhabdomyosarcoma 4 Lymphoma, Large-Cell, Anaplastic 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Recurrence 3 Lymphoma, Primary Effusion 3 Sarcoma, Ewing 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmablastic Lymphoma 2 Osteosarcoma 2 Neuroblastoma 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Hodgkin Disease 2 Enteropathy-Associated T-Cell Lymphoma 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1

Interventions

repotrectinib 1 pralsetinib 1 pamiparib 1 Vincristine 1 Temozolomide 1 Radiotherapy 1 Radiation 1 Maintenance Chemotherapy 1 Lomustine 1 Interleukin-12 1 Cisplatin 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡